Cambridge Investment Research Advisors, Inc. Journey Medical Corp Transaction History
Cambridge Investment Research Advisors, Inc.
- $27.1 Billion
- Q2 2024
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Journey Medical Corp stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 294,950 shares of DERM stock, worth $1.49 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
294,950Holding current value
$1.49 Million% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding DERM
# of Institutions
37Shares Held
3.11MCall Options Held
0Put Options Held
0-
B. Riley Securities, Inc. Los Angeles, CA865KShares$4.36 Million0.36% of portfolio
-
Vanguard Group Inc Valley Forge, PA310KShares$1.56 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny264KShares$1.33 Million0.0% of portfolio
-
American Financial Group Inc180KShares$907,2000.44% of portfolio
-
Pvg Asset Management Corp Golden, CO159KShares$799,0413.82% of portfolio
About Journey Medical Corp
- Ticker DERM
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 11,596,500
- Market Cap $58.4M
- Description
- Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat...